Matinas Biopharma Holdings Inc.

Last updated September 27, 2026

Organization details

Legal name
Matinas Biopharma Holdings Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Bedminster
Headquarters state / province
New Jersey
Headquarters country
United States
Fiscal year end
December
Ticker symbol
MTNB
Primary stock exchange
NYSE American

Identifiers

SEC CIK
0001582554
EIN
46-3011414

Board of directors

Chief executives

Jerome D. Jabbour · President and CEO
Dates unknown

Director election results

Annual meeting of June 23, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

8 of this board's directors also sit on 8 other boards. 7 are in the same sector.

Network of Matinas Biopharma Holdings Inc.'s board connections Backblaze Inc. Backblaze Inc. Celldex Therapeutics Inc. Celldex Therapeutics I... Celularity Inc. Celularity Inc. Grace Therapeutics Inc. Grace Therapeutics Inc... Indaptus Therapeutics Inc. Indaptus Therapeutics... Marker Therapeutics Inc. Marker Therapeutics In... Oragenics Inc. Oragenics Inc. VivoSim Labs Inc. VivoSim Labs Inc. An Evelyn D. An Evelyn D. Edward Neugeboren Edward Neugeboren Herbert J. Conrad Herbert J. Conrad Jerome D. Jabbour Jerome D. Jabbour Kathryn Penkus Corzo Kathryn Penkus Corzo Keith Murphy Keith Murphy Natasha Giordano Natasha Giordano Robin L. Smith Robin L. Smith Matinas Biopharma Holdings...
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Jul 10, 2026 Adam K. Stern 10% owner In-the-money exercise +344,710 $0.35 $120,649
Jul 10, 2026 Adam K. Stern 10% owner In-the-money exercise +630,335 $0.35 $220,617
Oct 31, 2025 Adam K. Stern 10% owner In-the-money exercise +92,100 $0.64 $58,944

Organizations in the same sector, closest in location and size first.

Questions about Matinas Biopharma Holdings Inc.

Who is the CEO of Matinas Biopharma Holdings Inc.?

Jerome D. Jabbour is Matinas Biopharma Holdings Inc.'s President and CEO.

How many directors are on Matinas Biopharma Holdings Inc.'s board?

Matinas Biopharma Holdings Inc.'s board has 11 directors: An Evelyn D., Edward Neugeboren, Eric J. Ende, Herbert J. Conrad, James S. Scibetta, Jerome D. Jabbour, Kathryn Penkus Corzo, Keith Murphy, Matthew Wikler, Natasha Giordano and 1 other.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="matinas-biopharma-holdings-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.